Op. Dr. Hakan Öztürk kimdir? Op. Dr. Hakan Öztürk Yorumları

Op. Dr. Hakan ÖZTÜRK 15 Ocak 1974 senesinde Erzurum’da doğdu. Ortaokul ve lise eğitimini İstanbul Pendik Lisesi’nde tamamladı. 1997 senesinde Uludağ Üniversitesi’nden mezun olduktan sonra İzmir Atatürk Eğitim ve Araştırma Hastanesinde Üroloji ihtisasına başladı. İhtisas eğitimi süresinde Avrupa Üroloji Derneği’nin Üroloji klavuzlarının Türkçe’ye çevrilmesi ve ürologlar içinde yaygınlaşması için çalıştı. 2003 senesinde üroloji uzmanı unvanını mesane kanseri nasıl tedavi edileceğinde “Radikal Sistektomi Daha sonra Seröz Hatlı Extra-mural Üreter İmplantasyonlu Ortotopik “W” İleal Yeni Mesane’nin Fonksiyonel ve Ürodinamik Analizi” tezini tamamlayarak aldı.

Aynı yıl tezin konusu Amerikan Üroloji Kongresi’nde “Oral Sunu” olarak kabul edildi. Aynı klinikte özellikle ürolojik kanserler üzerine çalışan Dr. Öztürk 2004-2016 senelerı içinde özel bir hastanede operatör doktor olarak çalıştı ve 2013 senesinden Yardımcı Doçent unvanını aldı. Bu alanda kitap bölüm yazarlığı da bulunmaktadır.

Ulusal ve ülkeler arası bilimsel toplantılarda konuşmacı olan Dr. Öztürk 2014 senesinde ABD’de tertip edilen “4th World Congress on Cancer Science & Therapy” kongresinde “Böbrek Sarkomları” hususunda konuşmacı olarak görev almıştır. 2015 senesinde Almanya Berlin’de tertip edilen “6th World Congress on Targeting Mitochondria” kongresine katılan olarak “Mitokondri Transplantasyonu” hususunda konuşmacı olarak görev yapmıştır. Dr. Öztürk’ün temel ilgi alanı ürolojik kanserler olan; prostat kanseri, mesane kanseri, böbrek kanseri ve testis kanserinin bunun yanında prostat hastalıklarıdır.

Laparoskopik kanser cerrahisi bir diğer ilgi alanı olan Dr. Öztürk 2012 senesinde kurduğu “PROSTATCA ULUSLARARASI KANSER ARAŞTIRMALARI” ile Uluslararası kanser araştırmalarında yardımcı araştırmacı olarak görev almaktadır. Uluslararası dergilerde hakem ve editorlük görevini aktif bir biçimde yürütmektedir. Türk Üroloji Derneği, Türk Androloji Derneği, Endoüroloji Derneği ve ülkeler arası American Society of Clinical Oncology, European Association of Urology, European Society for Medical Oncology, American Society for Radiation Oncology, European SocieTy for Radiotherapy and Oncology, European Society of Surgical Oncology,International Society of Geriatric Oncology, American Association for Cancer Research, European Association for Cancer Research, Urological Association of Asia üyelikleri bulunan Dr. Öztürk halen Medicalpark İzmir Hastanesinde Op. Dr. olarak çalışmaktadır.

Bilimsel Yayınlar:

Öztürk H. Comparing   RECIST  with  EORTC Criteria in Metastatic Bladder Cancer  J Cancer Res Clin Oncol. 2016 Jan;142(1):187-94.

Öztürk H.  Treatment of recurrent vesicourethral anastomotic stricture after radical prostatectomy using plasma-button vaporization. Scand J Urol. 2015 Feb 19:1-6.

Öztürk H, Karapolat I. Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy. Exp Ther Med. 2015 Mar;9(3):717-724.
  
Ozturk H. Detecting Metastatic Bladder Cancer Using 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography. Cancer Res Treat. 2015 Feb 12.

Ozturk H. High-grade Primary  Renal  Leiomyosarcoma. Int Braz J Urol. 2015 Mar-Apr;41(2):304-311.

Öztürk H. Diagnostic role of 18f-fluorodeoxyglucose positron-emission tomography/computed tomography in restaging renal cell carcinoma. Minerva Urol Nefrol. 2015 Apr 28.

Ozturk H. Tubeless versus standard PCNL in geriatric population. Actas Urol Esp. 2015 Apr 30.

Saracoglu M. Ozturk H. Duran a. Atalay S.  The Microorganisms Isolated From Urine And Ejaculate Samples And The Antibiotic Susceptibilities – kasmera.

Saracoglu M. Ozturk H. Duran A. Atalay S.   The Relationship Between Coronal Sulcus Lymphangitis And IgE   Revista Internacional de Andrología 

Ozturk H, I Karapolat.  18F-Fluorodeoxyglucose(FDG)-PET/CT for Detection Of Disease In Patients With Prostate-Specific Antigen Relapse After Radical Treatment of a Local Stage Prostate Cancer  Oncol Lett. 11: 316-322, 2016.

Oztürk H. Gastrointestinal System Complications in Percutaneous Nephrolithotomy: A Systematic Review. . J Endourol. 2014 Nov;28(11):1256-67.
 
Öztürk H. Prognostic features of renal sarcomas (Review). Oncol Lett. 2015 Mar;9(3):1034-1038.

Oztürk H. Renal Mucinous Tubular and Spindle Cell Carcinoma and (18)F-Fluorodeoxyglucose-PET/CT Findings. Clin Genitourin Cancer. 2014 Aug;12(4):e161-6.

Ozturk H, Karaaslan S. Uretheral invagination of multilocular cystic nephroma; a case report of a new pathologic variant. Int J Clin Exp Pathol. 2014 Jul 15;7(8):5271-9.   

Ozturk H, Karaaslan S. Metachronous Adrenal Metastasis From Operated Contralateral Renal Cell Carcinoma With Adrenalectomy And Iatrojenic Addison Disease.  Can Urol Assoc J 2014;8(9-10):e744-8.  

Ozturk H. Peripheral neuroectodermal tumour of the kidney (Ewing’s sarcoma): Restaging with 18F-fluorodeoxyglucose (FDG)-PET/CT. Can Urol Assoc J 2015 Jan-Feb;9(1-2):E39-44.

Öztürk H. Penile mucinous carcinoma: A case report. Oncol Lett. 2015 Mar;9(3):1293-1296. Epub 2014 Dec 30.

Öztürk H. Bilateral synchronous adrenal metastases of renal cell carcinoma: A case report and review of the literature. Oncol Lett. 2015 Apr;9(4):1897-1901.

Ozturk H. Penile Mondor’s disease; diagnosis with magnetic resonance imaging. Revista Internacional de Andrologia; Jul-Sep. 2015;13(3):104-108.

Oztürk H. Re: Wong et al.: Is Percutaneous Nephrolithotomy in Solitary Kidneys Safe? (Urology 2013;82:1013-1016). Urology. 2014 Apr;83(4):959.
 
Ozturk H, Saracoglu M, Zengin T, Sivrikoz ON, Kerman HS, Adakan S. Asymptomatic Sertoli cell tumour diagnosed during azoospermia work-up. Asian J Androl. 2013 Nov;15(6):845-6.

Ozturk H. Genetic Architecture of Renal Cell Carcinoma: Do We Have To Know? World J Urol. 2015 Sep 28.

Ozturk H. How do PDE5 Inhibutors close to solution at the treatment of BPH?  J Clin Pharmacol. 2015 Aug 27.
Öztürk H.  How real is the uterine transplantation? Ann Transplant. 2014 Feb 14;19:82-3.

Oztürk H. Neurologic complications of percutaneus nephrolithotomy. Int Neurourol J. 2014 Mar;18(1):45-7.
Karaarslan S, Yaman B, Ozturk H, Kumbaraci BS. Parafibromin Staining Characteristics in Urothelial Carcinomas and Relationship with Prognostic Parameters. J Pathol Transl Med. 2015 Sep;49(5):389-95.
 
Saracoglu M, Ozturk H, Zengin T, Kerman HS. Comparison of thermal cautery-assisted circumcision with the conventional technique.  Human Andrology:  June 2014 – Volume 4 – Issue 2 – p 34–37

Saracoglu M,Ozturk H, Duran A , Atalay S. Effect of microorganisms on etiology of hematospermia. Arch Ital Urol Androl. 2015 Mar 31;87(1):80-2.

Öztürk H.  Penile Mondor’s Disease. Basic and Clinical Andrology 2014, 24:5

Ozturk H. Elective Urological Surgery Following  Coronary Stent  Implantation  To Whom, How To Do it?. Curr Urol. 2014 Oct;7(4):169-73.

Saraçoglu M, Öztürk H. Female Circumcision.  Andrology & Gynecology: Current Research 2014, 2:2

Saracoglu M, Zengin T, Ozturk H, Genc M. Female Genital Mutilation/Cutting Type 4. J Androl Gynaecol. 2014 Dec;2(4): 5.  

Öztürk H, Saraçoglu M, Karaarslan S, Zengin T, Gülşen A, Kalaycıoğlu S.  A case of renal tuberculosis diagnosed during percutaneous nephrolithotomy. Case Reports in Clinical Medicine 2013 Vol.2, No.7, 411-414

Ozturk H, Sivrikoz ON.  High-Grade Primary Spindle Cell Sarcoma of the Prostate: A Case Report and Review of the Literature. World J Oncol. 2013;4(6):258-261.

Ozturk H, Karaaslan S.  High-Grade Primary Leiomyosarcoma of the Kidney.  World J Nephrol Urol. 2014;3(1):63-65
  
Ozturk H. Adrenal Ganglioneuroma Presenting As Left Renal Mass.  World J Oncol. 2014;5(2):90-92.

Ozturk H.  Vena Cava Invasion By Adrenal  leiomyosarcoma. Rare tumors 2014 Jun 23;6(2):5275,55-6. 

Ozturk H. Intrarenal Pseudoaneurysm After Percutaneous Nephrolithotomy at Solitary Kidney. Nephro Urol Mon. 2014 Sep; 6(5): e19037.  

Ozturk H, Multiple Carsinosarcomas Of The Kidney: A case report and review of the literature.   Molecular and Clinical Oncology  2015 Jan (3): 212-216.

Ozturk H, Karapolat I, Saklamaz A. Bilateral metachronous adrenal metastases of operated renal cell carcinoma. Urologia. 2015 Jun 11;82(2):114-7.

Ozturk H. 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney.  Indian J Nucl Med 2015 Jan-Mar;30(1):68-71.

Ozturk H. Primary spindle cell sarcoma of the prostate and 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography findings. Urol Ann. 2015 Jan;7(1):115-19.

Öztürk H. Evaluation of the response chemotherapy for penile metastasis of bladder cancer using 18F-fluorodeoxyglucose-PET/CT. Int J Surg Case Rep. 2015 Apr 14;11:33-36.

Öztürk H. Treatment of Colonic Injury During Percutaneous Nephrolithotomy. Rev Urol. 2015;17(3):194-201.

Ozturk H. Wireless Capsule Cystoscopy: How Near? How Far?.  Open Journal of Urology, 2014, 4, 37-40.
 
Ozturk H. Re: Parikh GP, Sonde SR, Kadam P. Venous air embolism: A complication during percutaneous nephrolithotomy. Indian J Urol 2014;30(4):456-7.  
Öztürk H. Comparing   RECIST  with  EORTC Criteria in Metastatic Bladder Cancer  J Cancer Res Clin Oncol. 2016 Jan;142(1):187-94.

Öztürk H.  Treatment of recurrent vesicourethral anastomotic stricture after radical prostatectomy using plasma-button vaporization. Scand J Urol. 2015 Feb 19:1-6.

Öztürk H, Karapolat I. Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy. Exp Ther Med. 2015 Mar;9(3):717-724.
  
Ozturk H. Detecting Metastatic Bladder Cancer Using 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography. Cancer Res Treat. 2015 Feb 12.

Ozturk H. High-grade Primary  Renal  Leiomyosarcoma. Int Braz J Urol. 2015 Mar-Apr;41(2):304-311.

Öztürk H. Diagnostic role of 18f-fluorodeoxyglucose positron-emission tomography/computed tomography in restaging renal cell carcinoma. Minerva Urol Nefrol. 2015 Apr 28.

Ozturk H. Tubeless versus standard PCNL in geriatric population. Actas Urol Esp. 2015 Apr 30. pii: 00119-9.

Saracoglu M. Ozturk H. Duran a. Atalay S.  The Microorganisms Isolated From Urine And Ejaculate Samples And The Antibiotic Susceptibilities – kasmera.

Saracoglu M. Ozturk H. Duran A. Atalay S.   The Relationship Between Coronal Sulcus Lymphangitis And IgE   Revista Internacional de Andrología 

Ozturk H, I Karapolat.  18F-Fluorodeoxyglucose(FDG)-PET/CT for Detection Of Disease In Patients With Prostate-Specific Antigen Relapse After Radical Treatment of a Local Stage Prostate Cancer  Oncol Lett. 11: 316-322, 2016.

Oztürk H. Gastrointestinal System Complications in Percutaneous Nephrolithotomy: A Systematic Review. . J Endourol. 2014 Nov;28(11):1256-67.
 
Öztürk H. Prognostic features of renal sarcomas (Review). Oncol Lett. 2015 Mar;9(3):1034-1038.

Oztürk H. Renal Mucinous Tubular and Spindle Cell Carcinoma and (18)F-Fluorodeoxyglucose-PET/CT Findings. Clin Genitourin Cancer. 2014 Aug;12(4):e161-6.

Ozturk H, Karaaslan S. Uretheral invagination of multilocular cystic nephroma; a case report of a new pathologic variant. Int J Clin Exp Pathol. 2014 Jul 15;7(8):5271-9.   

Ozturk H, Karaaslan S. Metachronous Adrenal Metastasis From Operated Contralateral Renal Cell Carcinoma With Adrenalectomy And Iatrojenic Addison Disease.  Can Urol Assoc J 2014;8(9-10):e744-8.  

Ozturk H. Peripheral neuroectodermal tumour of the kidney (Ewing’s sarcoma): Restaging with 18F-fluorodeoxyglucose (FDG)-PET/CT. Can Urol Assoc J 2015 Jan-Feb;9(1-2):E39-44.

Öztürk H. Penile mucinous carcinoma: A case report. Oncol Lett. 2015 Mar;9(3):1293-1296.

Öztürk H. Bilateral synchronous adrenal metastases of renal cell carcinoma: A case report and review of the literature. Oncol Lett. 2015 Apr;9(4):1897-1901.

Ozturk H. Penile Mondor’s disease; diagnosis with magnetic resonance imaging. Revista Internacional de Andrologia; Jul-Sep. 2015;13(3):104-108.

Oztürk H. Re: Wong et al.: Is Percutaneous Nephrolithotomy in Solitary Kidneys Safe? (Urology 2013;82:1013-1016). Urology. 2014 Apr;83(4):959.
 
Ozturk H, Saracoglu M, Zengin T, Sivrikoz ON, Kerman HS, Adakan S. Asymptomatic Sertoli cell tumour diagnosed during azoospermia work-up. Asian J Androl. 2013 Nov;15(6):845-6.

Ozturk H. Genetic Architecture of Renal Cell Carcinoma: Do We Have To Know? World J Urol. 2015 Sep 28.

Ozturk H. How do PDE5 Inhibutors close to solution at the treatment of BPH?  J Clin Pharmacol. 2015 Aug 27.       
Öztürk H.  How real is the uterine transplantation? Ann Transplant. 2014 Feb 14;19:82-3.

Oztürk H. Neurologic complications of percutaneus nephrolithotomy. Int Neurourol J. 2014 Mar;18(1):45-7.
Karaarslan S, Yaman B, Ozturk H, Kumbaraci BS. Parafibromin Staining Characteristics in Urothelial Carcinomas and Relationship with Prognostic Parameters. J Pathol Transl Med. 2015 Sep;49(5):389-95.
 
Saracoglu M, Ozturk H, Zengin T, Kerman HS. Comparison of thermal cautery-assisted circumcision with the conventional technique.  Human Andrology:  June 2014 – Volume 4 – Issue 2 – p 34–37

Saracoglu M,Ozturk H, Duran A , Atalay S. Effect of microorganisms on etiology of hematospermia. Arch Ital Urol Androl. 2015 Mar 31;87(1):80-2.

Öztürk H.  Penile Mondor’s Disease. Basic and Clinical Andrology 2014, 24:5  

Ozturk H. Elective Urological Surgery Following  Coronary Stent  Implantation  To Whom, How To Do it?. Curr Urol. 2014 Oct;7(4):169-73.

Saraçoglu M, Öztürk H. Female Circumcision.  Andrology & Gynecology: Current Research 2014, 2:2 

Saracoglu M, Zengin T, Ozturk H, Genc M. Female Genital Mutilation/Cutting Type 4. J Androl Gynaecol. 2014 Dec;2(4): 5.  

Öztürk H, Saraçoglu M, Karaarslan S, Zengin T, Gülşen A, Kalaycıoğlu S.  A case of renal tuberculosis diagnosed during percutaneous nephrolithotomy. Case Reports in Clinical Medicine 2013 Vol.2, No.7, 411-414

Ozturk H, Sivrikoz ON.  High-Grade Primary Spindle Cell Sarcoma of the Prostate: A Case Report and Review of the Literature. World J Oncol. 2013;4(6):258-261.

Ozturk H, Karaaslan S.  High-Grade Primary Leiomyosarcoma of the Kidney.  World J Nephrol Urol. 2014;3(1):63-65
  
Ozturk H. Adrenal Ganglioneuroma Presenting As Left Renal Mass.  World J Oncol. 2014;5(2):90-92.

Ozturk H.  Vena Cava Invasion By Adrenal  leiomyosarcoma. Rare tumors 2014 Jun 23;6(2):5275,55-6. 

Ozturk H. Intrarenal Pseudoaneurysm After Percutaneous Nephrolithotomy at Solitary Kidney. Nephro Urol Mon. 2014 Sep; 6(5): e19037.  

Ozturk H, Multiple Carsinosarcomas Of The Kidney: A case report and review of the literature.   Molecular and Clinical Oncology  2015 Jan (3): 212-216.

Ozturk H, Karapolat I, Saklamaz A. Bilateral metachronous adrenal metastases of operated renal cell carcinoma. Urologia. 2015 Jun 11;82(2):114-7.

Ozturk H. 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney.  Indian J Nucl Med 2015 Jan-Mar;30(1):68-71.

Ozturk H. Primary spindle cell sarcoma of the prostate and 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography findings. Urol Ann. 2015 Jan;7(1):115-19.

Öztürk H. Evaluation of the response chemotherapy for penile metastasis of bladder cancer using 18F-fluorodeoxyglucose-PET/CT. Int J Surg Case Rep. 2015 Apr 14;11:33-36.

Öztürk H. Treatment of Colonic Injury During Percutaneous Nephrolithotomy. Rev Urol. 2015;17(3):194-201.

Ozturk H. Wireless Capsule Cystoscopy: How Near? How Far?.  Open Journal of Urology, 2014, 4, 37-40.
 
Ozturk H. Re: Parikh GP, Sonde SR, Kadam P. Venous air embolism: A complication during percutaneous nephrolithotomy. Indian J Urol 2014;30(4):456-7.  

Solak A, Öztürk H, Şahin N, Saraçoğlu M, Kalaycığolu S, Genç B. Mesane çıkışı obstrüksiyonunun non-invaziv tanısında intravezikal prostatik protüzyonun önemi: Semptomlar ve üroflowmetrik sonuçlarla korelasyon. Yeni Tıp Dergisi 2013;30:220-223.

Saraçoğlu M, Öztürk H, Zengin T. Ürodinamik Çalışmaların Tedavinin Yönlendirilmesine Katkısı Nedir?  The Cystoscope 2014:189-195. 

Öztürk H. Geriatrik Popülasyonda Alfa-Bloker ve Antikolinerjik Kullanımının Sistemik Etkileri. Akademik geriatri dergisi 2014 Haziran;6(2).62-72. 

Öztürk  H.  Prostat Kanseri Tedavisinin Geleceği; Apopitoz mu? The Cystoscope 2013:1 (6-9.)

Öztürk H.  Gümüş B.  Metabolik sendrom ve kadınlarda seksüel disfonksiyon.  Androloji bülteni 2014; Mar (56): 77-82.  

Saraçoğlu M, Özturk H, Zengin T, Gümüş B.  Erkeklerde genital pirsing. Androloji bülteni 2014; Ara (59): 222-226.  

Zengin T, Saraçoğlu M, Karaaslan S, Öztürk H. Spermatik Kordda Adrenal Ektopik Doku ve Testisde Spermatositik Seminom Birlikteliği; Literatüre Kısa Bakış.  The Cystoscope 2013:1 (55-57).

Uşar P, Kar AA, Maral J, Yalaz S, Ozturk H. Genel Anestezi Sonrası Gelişen Negatif Basınç Akciğer Ödemi Journal of Anesthesia – JARSS 2014; 22 (2): 116 – 119.   

Yalçın M, Saklamaz A, Doğan F, Yılmaz H, Öztürk H, Aykır H. Ciddi Hipolaksemi Gelişen Yaygın Osteoblastik Kemik Metastazlı Prostat Kanserli Bir Hasta. Ege Klin. Tıp. Der. Nisan 2015(53):1;144-148.

Öztürk H, Saraçoğlu M, Zengin T, Kerman HS.  Benign Prostat Hiperplazisi ve Aşırı Aktif Mesane Birlikteliğine Güncel Bakış.  Türkiye Klinikleri J Urology 2013;4(2):82-7.

Uluslararası Bildiriler:
Atesci YZ, Aydogdu O, Karakose A, Ozturk H. W-pouch Ileal Neobladder For Continent diversion: Does The Use Of Double-J-Stents To Support The Ureteroileal Anastomosis Increase The Risk Of Early Renal Failure? Poster number: 14/1147 American Urological association(AUA) 17 May, 2014

Ozturk H. Facilitate Stent Removal; Magnetic DJ stent   Euro-challanges  conggres 28-30 Jun 2015 Paris-France

Ozturk H, Title: Prognostic features of renal sarcomas. 4th World Congress on  Cancer Science & Therapy. October 20-22, 2014 DoubleTree by Hilton Hotel Chicago-North Shore Conference Center, USA

Ozturk H, Title: Mitochondria transplantation: Why? . 6th World Congress on  Targeting Mitochondria October 28-30, 2015 Ritz Carlton Berlin-Germany.